The University of Bristol paper, published today in Cell Reports, describes the role two main types of nicotinic receptor (α7 and α4β2 receptors) play in long-term memory retrieval and encoding ...

DUBLIN--(BUSINESS WIRE)--The "Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

Tests using mice employed an experimental drug that stimulates a specific type of nicotinic receptor in immune cells; researchers attested the reversion of the inflammation condition. The results ...

A new study, however, shows that pharmacological stimulation of a specific type of nicotinic receptor in cells of the immune system could be a strategy to treat inflammatory lung disease.

Currently, the main treatments for Alzheimer’s disease are drugs that increase levels of acetylcholine in the brain. The University of Bristol paper, published today in Cell Reports, describes the ...

When nicotine enters the brain, it binds to nicotinic acetylcholine receptors (nAChRs) on the surface of neurons. Usually bound to by the neurotransmitter acetylcholine, activation of these excitatory ...

A role for β2* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus. Neurobiology of Aging , 2016; 46: 221 DOI: 10.1016/j.neurobiolaging.2016.06.005 Cite This Page : ...

Three-dimensional structures of nicotinic acetylcholine receptor determined by cryo-EM, courtesy of Hibbs Lab. "When this receptor binds to either the neurotransmitter acetylcholine or to nicotine ...

Acta Pharmacologica Sinica - Expression of nicotinic acetylcholine receptor subunit α9 in type II vestibular hair cells of rats Skip to main content Thank you for visiting nature.com.

The nicotinic acetylcholine receptor (AChR) is assembled on the cell surface from multiple subunits produced in the endoplasmic reticulum (ER), but how these mechanisms are controlled has been unclear ...

Using mouse models for Alzheimer's disease, they identified the β2 subunit of the nicotinic receptor as a target that, if blocked, prevents the memory loss associated with Alzheimer's.